tiprankstipranks
HUTCHMED (China) Limited (GB:HCM)
LSE:HCM

Compare HUTCHMED (China) (HCM) vs. Competitors

6 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
HUTCHMED (China)
204.00 p
£1.95B
4.97
11.96%
10 Buy
0 Hold
1 Sell
Strong Buy
China Medical System Holdings
HK$14.20
HK$34.89B
19.33
91.84%
3 Buy
0 Hold
0 Sell
Strong Buy
Livzon Pharmaceutical Group
HK$30.94
HK$31.87B
11.61
9.46%
0 Buy
0 Hold
1 Sell
Moderate Sell
Shanghai Fosun Pharmaceutical (Group) Co
HK$19.63
HK$75.27B
14.15
41.21%
2 Buy
0 Hold
0 Sell
Moderate Buy
Hansoh Pharmaceutical Group Company Limited
HK$38.76
HK$234.70B
35.71
70.18%
7 Buy
0 Hold
0 Sell
Strong Buy
CanSino Biologics, Inc. Class H
HK$44.94
HK$13.09B
292.71
11.18%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GB:HCM
HUTCHMED (China)
220.00
-5.00
-2.22%
HK:0867
China Medical System Holdings
13.87
6.55
89.48%
HK:1513
Livzon Pharmaceutical Group
28.24
3.00
11.89%
HK:2196
Shanghai Fosun Pharmaceutical (Group) Co
19.60
5.77
41.73%
HK:3692
Hansoh Pharmaceutical Group Company Limited
38.46
15.91
70.55%
HK:6185
CanSino Biologics, Inc. Class H
33.02
2.77
9.16%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts